Your browser doesn't support javascript.
loading
Durable natural killer cell response after three doses of SARS-CoV-2 inactivated vaccine in HIV-infected individuals.
Yang, Xiaodong; Wang, Xiuwen; Zhang, Xin; Ding, Haifeng; Wang, Hu; Huang, Tao; Zhang, Guanghui; Duan, Junyi; Xia, Wei; Su, Bin; Jin, Cong; Wu, Hao; Zhang, Tong.
Affiliation
  • Yang X; Beijing Key Laboratory for HIV/AIDS Research, Sino-French Joint Laboratory for Research on Humoral Immune Response to HIV Infection, Clinical and Research Center for Infectious Diseases, Beijing Youan Hospital, Capital Medical University, Beijing 100069, China.
  • Wang X; Beijing Key Laboratory for HIV/AIDS Research, Sino-French Joint Laboratory for Research on Humoral Immune Response to HIV Infection, Clinical and Research Center for Infectious Diseases, Beijing Youan Hospital, Capital Medical University, Beijing 100069, China.
  • Zhang X; Beijing Key Laboratory for HIV/AIDS Research, Sino-French Joint Laboratory for Research on Humoral Immune Response to HIV Infection, Clinical and Research Center for Infectious Diseases, Beijing Youan Hospital, Capital Medical University, Beijing 100069, China.
  • Ding H; National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China.
  • Wang H; Beijing Key Laboratory for HIV/AIDS Research, Sino-French Joint Laboratory for Research on Humoral Immune Response to HIV Infection, Clinical and Research Center for Infectious Diseases, Beijing Youan Hospital, Capital Medical University, Beijing 100069, China.
  • Huang T; Tian Yuan Studio, Beijing Youan Hospital, Capital Medical University, Beijing 100069, China.
  • Zhang G; Tian Yuan Studio, Beijing Youan Hospital, Capital Medical University, Beijing 100069, China.
  • Duan J; Tian Yuan Studio, Beijing Youan Hospital, Capital Medical University, Beijing 100069, China.
  • Xia W; Beijing Key Laboratory for HIV/AIDS Research, Sino-French Joint Laboratory for Research on Humoral Immune Response to HIV Infection, Clinical and Research Center for Infectious Diseases, Beijing Youan Hospital, Capital Medical University, Beijing 100069, China.
  • Su B; Beijing Key Laboratory for HIV/AIDS Research, Sino-French Joint Laboratory for Research on Humoral Immune Response to HIV Infection, Clinical and Research Center for Infectious Diseases, Beijing Youan Hospital, Capital Medical University, Beijing 100069, China.
  • Jin C; National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China.
  • Wu H; Beijing Key Laboratory for HIV/AIDS Research, Sino-French Joint Laboratory for Research on Humoral Immune Response to HIV Infection, Clinical and Research Center for Infectious Diseases, Beijing Youan Hospital, Capital Medical University, Beijing 100069, China.
  • Zhang T; Beijing Key Laboratory for HIV/AIDS Research, Sino-French Joint Laboratory for Research on Humoral Immune Response to HIV Infection, Clinical and Research Center for Infectious Diseases, Beijing Youan Hospital, Capital Medical University, Beijing 100069, China.
Chin Med J (Engl) ; 136(24): 2948-2959, 2023 Dec 20.
Article in En | MEDLINE | ID: mdl-38018259
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: HIV Infections / COVID-19 Limits: Humans Language: En Journal: Chin Med J (Engl) Year: 2023 Document type: Article Affiliation country: China Country of publication: China
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: HIV Infections / COVID-19 Limits: Humans Language: En Journal: Chin Med J (Engl) Year: 2023 Document type: Article Affiliation country: China Country of publication: China